InsurTech Unicorn Alan Secures €480 Million Series G to Scale 'Prevention Insurance' Globally
Overview of the Funding Landmark
The Paris-based digital health insurance pioneer, Alan, has announced the closing of a major €480 million ($550 million) Series G financing round. Led by Dutch technology investor Prosus, the fresh capital injection elevates Alan’s valuation to €5.5 billion ($6.3 billion).
The funding represents one of the largest European tech transactions of the year outside of pure-play artificial intelligence. It marks a monumental step-up for the startup, which secured a €100 million primary capital raise just three months prior at a €5.0 billion valuation.
Key Investors in the Series G Syndicate
- Prosus (Lead investor, contributing €400 million through primary and secondary equity)
- Teachers' Venture Growth (TVG) (Existing shareholder, representing Ontario Teachers' Pension Plan)
- Index Ventures (Existing shareholder)
- Dara Holdings (New investor)
Pioneering "Prevention Insurance"
Founded in 2016 by Jean-Charles Samuelian-Werve and Charles Gorintin, Alan was initially recognized as France’s first newly licensed health insurer in over thirty years. Today, the company is redefining the sector by moving beyond reactive claims-processing to champion a model they call "prevention insurance."
Unlike traditional systems where insurance only intervenes after a patient falls ill, Alan’s unified platform integrates:
- Comprehensive Health Coverage: Seamless, automated medical reimbursement services where 70% of claims are processed in under an hour.
- Proactive Prevention & Care Navigation: Personalized wellbeing services, virtual clinics, and digital optical tools.
- AI-Powered Assistance: The platform leverages "Mo," an AI health companion that monitors member wellbeing, answers coverage questions, and flags potential health risks proactively.
Strategic Growth and International Expansion
Alan plans to utilize the Series G capital to deepen its presence in its four core operating countries—France, Belgium, Spain, and Canada—while accelerating its entry into new global markets.
Target: Challenging Canada's Health Benefits Market
A primary focus of the new funding is Canada. Since obtaining its federal license in late 2024, Alan has positioned itself to challenge the country's highly concentrated group benefits market, which is currently dominated by three major incumbents. Having tripled its member volume in Canada since the end of 2025, Alan is actively scaling its services to larger employers.
Leveraging Advanced AI
Through its partnership with Prosus, Alan will gain access to cutting-edge AI capabilities, including Prosus's Large Commerce Model (LCM). By incorporating these AI models, the company aims to expand personalized preventative care to a broader audience without incurring unsustainable administrative overhead.
Strong Financial Momentum
Alan’s massive funding round is underpinned by robust operational metrics. In the first quarter of 2026, the company reached several major milestones:
- Annual Recurring Revenue (ARR): Surpassed €804 million (a 53% year-over-year increase).
- Member Base: Expanded to serve over 1.1 million members across 37,000 businesses.
- Profitability: Reached EBITDA-level profitability within its primary French market, validating the financial sustainability of its digital-first, preventive care model.
The final closing of the Series G transaction remains subject to standard regulatory approvals, including clearance from France's financial supervisor, the Prudential Supervision and Resolution Authority (ACPR).